Theratechnologies Inc.

Theratechnologies Inc.

Theratechnologies is pepped up on peptides. The Canadian company develops peptide sequences to treat endocrine and metabolic conditions such as growth hormone deficiencies. Lead drug candidate tesamorelin is a growth hormone-releasing peptide that Theratechnologies believes can combat a variety of problems, including HIV-related lipodystrophy (the metabolic syndrome characterized by changes in distribution of adipose tissue), muscle wasting associated with chronic obstructive pulmonary disease, sleep maintenance insomnia, and immune dysfunction in elderly patients.

Contact Details

Office Address

Theratechnologies Inc.
2310 Alfred-Nobel Blvd.
Montréal, Québec, Canada H4S2B4
Phone: (514) 336-7800
Fax: (514) 336-7242



Paul Pommier

President, CEO, and Director

Yves Rosconi

Business Reviews for Theratechnologies Inc.

Related Companies